Noise‐reduction techniques for 1 H‐FID‐MRSI at 14.1 T: Monte Carlo validation and in vivo application
NMR in Biomedicine · 2024
DOI: 10.1002/nbm.5211 ↗Kurz gefasst
Fachartikel in der Zeitschrift NMR in Biomedicine, 2024. Verfasst von Brayan Alves und 9 weiteren Autor:innen. Beteiligte Einrichtung: CIBM Center for Biomedical Imaging, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Monte Carlo Method, Signal-To-Noise Ratio, Brain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.
Abstract (Originalsprache)
Proton magnetic resonance spectroscopic imaging ( 1 H‐MRSI) is a powerful tool that enables the multidimensional non‐invasive mapping of the neurochemical profile at high resolution over the entire brain. The constant demand for higher spatial resolution in 1 H‐MRSI has led to increased interest in post‐processing‐based denoising methods aimed at reducing noise variance. The aim of the present study was to implement two noise‐reduction techniques, Marchenko–Pastur principal component analysis (MP‐PCA) based denoising and low‐rank total generalized variation (LR‐TGV) reconstruction, and to test their potential with and impact on preclinical 14.1 T fast in vivo 1 H‐FID‐MRSI datasets. Since there is no known ground truth for in vivo metabolite maps, additional evaluations of the performance of both noise‐reduction strategies were conducted using Monte Carlo simulations. Results showed that both denoising techniques increased the apparent signal‐to‐noise ratio (SNR) while preserving noise properties in each spectrum for both in vivo and Monte Carlo datasets. Relative metabolite concentrations were not significantly altered by either method and brain regional differences were preserved in both synthetic and in vivo datasets. Increased precision of metabolite estimates was observed for the two methods, with inconsistencies noted for lower‐concentration metabolites. Our study provided a framework for how to evaluate the performance of MP‐PCA and LR‐TGV methods for preclinical 1 H‐FID MRSI data at 14.1 T. While gains in apparent SNR and precision were observed, concentration estimations ought to be treated with care, especially for low‐concentration metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CIBM Center for Biomedical Imaging, Lausanne, Switzerland.
- Animal Imaging and Technology, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
- Laboratory of Functional and Metabolic Imaging, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
- High-field MR Center, Department of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Vienna, Austria.
- Advanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland.
ORCID-Profile: Jessie Mosso, Thanh Phong Lê, Wolfgang Bogner, Bernard Lanz, Cristina Cudalbu
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Alves, B., Simicic, D., Mosso, J., Lê, T. P., Briand, G., Bogner, W., Lanz, B., Strasser, B., Klauser, A., & Cudalbu, C. (2024). Noise‐reduction techniques for 1 H‐FID‐MRSI at 14.1 T: Monte Carlo validation and in vivo application. NMR in Biomedicine. https://doi.org/10.1002/nbm.5211
Vancouver
Alves B, Simicic D, Mosso J, Lê TP, Briand G, Bogner W, et al. Noise‐reduction techniques for 1 H‐FID‐MRSI at 14.1 T: Monte Carlo validation and in vivo application. NMR in Biomedicine. 2024. doi:10.1002/nbm.5211
BibTeX
@article{Alves2024,
author = {Alves, Brayan and Simicic, Dunja and Mosso, Jessie and Lê, Thanh Phong and Briand, Guillaume and Bogner, Wolfgang and Lanz, Bernard and Strasser, Bernhard and Klauser, Antoine and Cudalbu, Cristina},
title = {Noise‐reduction techniques for 1 H‐FID‐MRSI at 14.1 T: Monte Carlo validation and in vivo application},
journal = {NMR in Biomedicine},
year = {2024},
doi = {10.1002/nbm.5211}
}
EUVIMED